Northwest Capital Management’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-26
Closed -$8.4K 134
2025
Q3
$8.4K Hold
26
0.01% 199
2025
Q2
$10.1K Hold
26
0.01% 271
2025
Q1
$11.3K Hold
26
﹤0.01% 304
2024
Q4
$9.59K Hold
26
﹤0.01% 314
2024
Q3
$13.5K Hold
26
﹤0.01% 297
2024
Q2
$14.1K Hold
26
0.01% 281
2024
Q1
$13.5K Hold
26
﹤0.01% 353
2023
Q4
$12.3K Hold
26
﹤0.01% 351
2023
Q3
$11.3K Hold
26
﹤0.01% 349
2023
Q2
$11.6K Buy
+26
New +$12K ﹤0.01% 355

Other funds holding ELV

Northwest Capital Management's ELV Position: Q4 2025 in Review

Northwest Capital Management sold out of Elevance Health (ELV) in Q4 2025, closing a stake of 26 shares — an estimated $8.4K sold.

Northwest Capital Management first reported a position in ELV in Q2 2023 and held it in 10 quarters. The position peaked at $14.1K in Q2 2024. 1,555 funds tracked by Wall St. Rank hold ELV as of Q4 2025.

  • Northwest Capital Management reported no remaining Elevance Health position as of Q4 2025 after selling out during the quarter.
  • Northwest Capital Management sold 26 Elevance Health shares in Q4 2025, an estimated $8.4K.
  • Northwest Capital Management first reported a position in Elevance Health in Q2 2023 and held it in 10 quarters.
  • Northwest Capital Management's Elevance Health position peaked at $14.1K in Q2 2024.
  • 1,555 funds tracked by Wall St. Rank held Elevance Health as of Q4 2025.

Based on Northwest Capital Management's 13F filing for Q4 2025, filed 26 Jan 2026.